follow up of Effects of Melatonin on Fatigue Associated associated with radiotherapy and chemotherapy
Phase 2
- Conditions
- Breast CanceCancer Related FatigueMelatonin.Malignant neoplasm of breast
- Registration Number
- IRCT20180426039421N3
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 64
Inclusion Criteria
Breast Cancer Stages I, II, III According to Pathological Reports
Patients at least 18 Years Old
Have Signed a Written Consent
Recevieng Adjuvant Chemotherapy and Radiotherapy
No Untreated Hypercalcemia
No Systolic Blood Pressure Less Than 100 mm Hg
No Warfarin Consumption
No Methylphenidate Consumption
No Sleep Pills During Melatonin Use
No TSH>5/5 or <0/5
No Pregnancy or Breastfeeding
Exclusion Criteria
Not signing a written consent
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue severity in the BFI questionnaire. Timepoint: 2 years after last adjuvant treatment session. Method of measurement: Brief Fatigue Inventory( BFI) questionnaire.
- Secondary Outcome Measures
Name Time Method